IL125856A - 7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL125856A
IL125856A IL12585697A IL12585697A IL125856A IL 125856 A IL125856 A IL 125856A IL 12585697 A IL12585697 A IL 12585697A IL 12585697 A IL12585697 A IL 12585697A IL 125856 A IL125856 A IL 125856A
Authority
IL
Israel
Prior art keywords
preparation
camptothecin derivatives
pharmaceutical compositions
pct
compositions containing
Prior art date
Application number
IL12585697A
Other languages
English (en)
Other versions
IL125856A0 (en
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125856(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of IL125856A0 publication Critical patent/IL125856A0/xx
Publication of IL125856A publication Critical patent/IL125856A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL12585697A 1996-02-23 1997-02-19 7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them IL125856A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali
PCT/EP1997/000786 WO1997031003A1 (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents

Publications (2)

Publication Number Publication Date
IL125856A0 IL125856A0 (en) 1999-04-11
IL125856A true IL125856A (en) 2001-08-26

Family

ID=11373368

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12585697A IL125856A (en) 1996-02-23 1997-02-19 7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (2) US6130227A (enExample)
EP (1) EP0885230B1 (enExample)
JP (1) JP4171527B2 (enExample)
KR (1) KR100497906B1 (enExample)
CN (1) CN1107677C (enExample)
AT (1) ATE221071T1 (enExample)
AU (1) AU718361B2 (enExample)
BR (1) BR9707622B1 (enExample)
CZ (1) CZ289268B6 (enExample)
DE (1) DE69714220T2 (enExample)
DK (1) DK0885230T3 (enExample)
EE (1) EE03529B1 (enExample)
ES (1) ES2180932T3 (enExample)
HU (1) HUP9900987A3 (enExample)
IL (1) IL125856A (enExample)
IT (1) IT1282673B1 (enExample)
NZ (1) NZ331126A (enExample)
PT (1) PT885230E (enExample)
RU (1) RU2165935C2 (enExample)
SK (1) SK283217B6 (enExample)
UA (1) UA49005C2 (enExample)
WO (1) WO1997031003A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211931T1 (de) * 1998-06-26 2002-02-15 Quanam Medical Corp Topoisomerase inhibitoren zur restenose- prevention
US7105492B2 (en) 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
PT1044977E (pt) * 1999-03-09 2002-09-30 Sigma Tau Ind Farmaceuti Derivados de camptotecina com actividade antitumoral
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
US6950757B2 (en) * 2001-04-11 2005-09-27 Emerald Biostructures, Inc. Screening methods for identifying ligands
RU2319482C2 (ru) * 2001-11-23 2008-03-20 Чугаи Сейяку Кабусики Кайся Способ идентификации противоопухолевых целевых ферментов
CN1276923C (zh) * 2002-03-01 2006-09-27 法玛西雅意大利公司 盐酸伊立替康的结晶多晶型物
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
PL1962850T3 (pl) * 2005-12-21 2012-07-31 Sigma Tau Ind Farmaceuti Leczenie lekoopornych nowotworów
WO2007095389A2 (en) * 2006-02-17 2007-08-23 Novacea, Inc. Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs
CN101033230B (zh) * 2006-03-10 2010-12-08 中国科学院上海药物研究所 一类喜树碱衍生物及其应用
ITMI20061474A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
CN104774209B (zh) * 2014-01-15 2018-06-19 上海海和药物研究开发有限公司 一种9-烯丙基喜树碱衍生物的合成方法
CN117940432A (zh) * 2021-09-01 2024-04-26 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
DE69728152T2 (de) * 1996-08-19 2004-08-05 Bionumerik Pharmaceuticals, Inc., San Antonio Hoch-lipophile campothecin-derivate

Also Published As

Publication number Publication date
SK112798A3 (en) 1999-01-11
US6306868B1 (en) 2001-10-23
JP2000505448A (ja) 2000-05-09
BR9707622B1 (pt) 2010-08-10
HUP9900987A3 (en) 2000-01-28
EP0885230B1 (en) 2002-07-24
UA49005C2 (uk) 2002-09-16
NZ331126A (en) 2000-02-28
CZ289268B6 (cs) 2001-12-12
CZ265298A3 (cs) 1999-01-13
CN1211987A (zh) 1999-03-24
EE03529B1 (et) 2001-10-15
ES2180932T3 (es) 2003-02-16
ATE221071T1 (de) 2002-08-15
EE9800259A (et) 1999-02-15
DK0885230T3 (da) 2002-11-18
HUP9900987A2 (hu) 1999-08-30
ITMI960338A0 (enExample) 1996-02-23
KR100497906B1 (ko) 2006-03-09
EP0885230A1 (en) 1998-12-23
RU2165935C2 (ru) 2001-04-27
US6130227A (en) 2000-10-10
IT1282673B1 (it) 1998-03-31
PT885230E (pt) 2002-12-31
AU1875397A (en) 1997-09-10
CN1107677C (zh) 2003-05-07
IL125856A0 (en) 1999-04-11
WO1997031003A1 (en) 1997-08-28
BR9707622A (pt) 1999-07-27
JP4171527B2 (ja) 2008-10-22
DE69714220T2 (de) 2002-11-14
DE69714220D1 (de) 2002-08-29
ITMI960338A1 (it) 1997-08-23
AU718361B2 (en) 2000-04-13
KR19990087110A (ko) 1999-12-15
SK283217B6 (sk) 2003-03-04

Similar Documents

Publication Publication Date Title
IL125856A (en) 7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them
NO950879L (no) 3-fenylpyrrolidin-derivater
TR200909479T2 (tr) Sinerjistik kombinasyon.
IL158784A (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, processes for their preparation and pharmaceutical compositions containing them
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
FI954898A7 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (es) Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales.
HUP0104987A3 (en) Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
HUP0105003A3 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
HUP0200210A3 (en) Camptothecin derivatives having antitumor activity, process for their preparation and pharmaceutical compositions containing them
HUP0105114A3 (en) Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
DK0939765T3 (da) Glycokonjugater af modificerede camptothecin-derivater (A- eller B-ringbinding)
HUP0200572A3 (en) Amine derivatives as protease inhibitors process for their preparation, pharmaceutical compositions containing them and their use
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
HUP0202186A3 (en) Benzimidazolone derivatives, process for their preparation, pharmaceutical compositions containing them and their use as phosphodiesterase inhibitors for producing pharmaceutical compositions
MY122391A (en) Piperazine derivatives as 5-ht1b antagonists
HUP0200996A3 (en) Amine derivatives, pharmaceutical compositions containing them and their use
SI0920426T1 (en) New thiazole derivatives with phosphodiesterase-inhibiting effect
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
HUP0203539A3 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
ATE318268T1 (de) Pyrazolyl-substituierte triazolochinoxaline
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees